Development of an assay for personalized synergistic blockade immunotherapy treatment of COVD-19 patients using CytoFind™

The current COVID-19 pandemic has posed many challenges to healthcare professionals as they deal with managing the primary disease and it many complications. The proposal aims to develop, test, and validate an assay to detect quickly immune checkpoint targets in T cells in peripheral blood with high specificity and sensitivity using a diagnostic device, CytoFind, […]

Read More
Next-Generation Precision Medicine Solutions – Diagnostics

As personalized medicine approaches aim to tailor treatments to individuals, improvements are needed in the detection of existing biomarkers and genomic, epigenomic, and proteomic changes that occur during disease development. This would have potential impact on medication selection and targeted therapy, reduce adverse effects, improve cost effectiveness, and shift the goal of medicine from reactive […]

Read More